Detalhe da pesquisa
1.
Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203.
Gynecol Oncol
; 175: 176-181, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37393743
2.
Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy.
Gynecol Oncol
; 154(1): 183-188, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31104905
3.
Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared With Conventional Pelvic Radiation Therapy: Updated Results of a Phase III Trial.
J Clin Oncol
; 40(27): 3115-3119, 2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35960897
4.
Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study.
J Clin Oncol
; 38(15): 1685-1692, 2020 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32073955
5.
Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203.
J Clin Oncol
; 36(24): 2538-2544, 2018 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29989857
6.
Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM).
Biomark Res
; 1(1): 29, 2013 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-24252135